M

oderna Therapeutics, biotech’s highest-profile and most richly funded startup, is losing another key executive, struggling to retain talent despite the company’s unwavering promise that it’s on pace to change the face of medicine.

Dr. Stephen Kelsey, head of Moderna’s oncology division, is leaving the company to work at a biotech startup in California, according to people familiar with the matter. Each spoke on condition of anonymity, citing strict nondisclosure agreements.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.